Notification of change of assay for EBV serology testing from Premier Meridian to Abbott Architect, to take effect on Monday 11th of May 2015
As part of our ongoing service improvement programme, we plan to move our EBV serology tests from the current Premier Meridian assay to the more automated Abbott Architect assay. This will allow a more rapid turnaround time for results, as well as a more responsive service.
A comparison of performance has shown that there is very little difference between these two assays, and we therefore expect no clinically significant impact on results obtained by switching to the new assay.
We plan to introduce the above change during the week beginning Monday 11th May. If you wish to discuss please do not hesitate to contact us. See link to notification letter here